Sinzen Medtech

Based in Shanghai, China and founded in 2020, Shanghai Shengzhi Medical Technology Co. , Ltd. , doing business as Sinzen Medtech, provides surgical device and medical technology solutions for the minimally invasive surgery market. The company has a 1,000-square-meter R&D center and a 10,000-level clean production workshop.

Jie Tang, its founder and CEO, graduated from Shanghai Jiao Tong University School of Medicine and previously worked at Edwards and Johnson & Johnson Medical Technologies. In May 2026, the company closed a series A funding led by Ennovation Ventures, with participation from Fong Capital Partners. Sinzen Medtech develops surgical equipment and platforms for minimally invasive procedures, including multi‑joint endoscopic surgical instruments (manual and electric), advanced energy platforms, and electrosurgical systems, with core products such as the “Zhirou” disposable multi‑joint endoscopic suturing device, the “Zhishui & Renshan” bipolar electrosurgical system, and electric multi‑joint endoscopic instruments under development. Its solutions integrate mechanical control, energy delivery technologies, and algorithm‑based precision control, supporting surgical workflows such as suturing, cutting, and hemostasis across multiple clinical specialties.

The company generates revenue primarily through the sale of surgical instruments, disposable devices, and electrosurgical systems, supported by medical device commercialization and distribution activities. The company will use the series A funding to support the construction of its production base in Ma'anshan, Anhui, research and development, commercialization, FDA & CE registration, and overseas expansion. Also, it will officially release the "ZhiRou" disposable multi-joint endoscopic monopolar electric hook in the second half of 2026.